A Pilot Study of the fMRI [functional magnetic resonance imaging ] Response to Leptin and Pramlintide
Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 07 Aug 2015
At a glance
- Drugs Metreleptin (Primary) ; Pramlintide (Primary)
- Indications Obesity
- Focus Pharmacodynamics; Pharmacokinetics
- 10 Jun 2017 Biomarkers information updated
- 05 Jun 2012 Planned End Date changed from 1 Dec 2009 to 1 Jul 2012 as reported by ClinicalTrials.gov record.
- 13 Feb 2009 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.